Not applicableStudy completedNCT03370380What this trial is testingAflibercept in Patients With Pigment Epithelial Detachments (PED)Who this might be right forPigment Epithelial Detachment University Hospital Muenster 18
Post-approval studies (Phase 4)WithdrawnNCT01666236What this trial is testingTriple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal VasculopathyWho this might be right forChoroidal NeovascularizationRetinal Pigment Epithelial Detachment Federal University of São Paulo
Not applicableUnknownNCT01521819What this trial is testingIray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular DegenerationWho this might be right forRetinal Pigment Epithelial Detachment With VascularizationAge Related Macular Degeneration Oraya Therapeutics, Inc. 12
Early research (Phase 1)Ended earlyNCT01334255What this trial is testingISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)Who this might be right forPigment Epithelial Detachment Lpath, Inc. 12
Post-approval studies (Phase 4)Study completedNCT02142296What this trial is testingEylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)Who this might be right forRetinal Pigment Epithelial Detachment Secondary to Age-related Macular Degeneration London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 37
Post-approval studies (Phase 4)Study completedNCT00976222What this trial is testingIntravitreal Ranibizumab in Retinal Pigment Epithelial DetachmentsWho this might be right forPigment Epithelial Detachment University Hospital Muenster 40